Stock listing
BWAY Stock Price, News, Filings & Events — Brainsway Ltd
Selected listing: BWAY · NASDAQ · USD · US
This page tracks Brainsway Ltd's BWAY:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BWAY:NASDAQ. BWAY:NASDAQ is the stock-level entry point for investors researching Brainsway Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Brainsway Ltd is a public company listed on the Israeli market under the ticker BWAY. The company has a market capitalization of approximately $651.3 million. Brainsway specializes in developing and commercializing innovative medical technologies, particularly in the field of neuromodulation.
- Ticker
- BWAY:NASDAQ
- Asset type
- Stock
- Market cap
- $583.7M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Brainsway Ltd BWAY:NASDAQ stock context
This page tracks Brainsway Ltd's BWAY:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BWAY:NASDAQ. BWAY:NASDAQ is the stock-level entry point for investors researching Brainsway Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Brainsway Ltd is a public company listed on the Israeli market under the ticker BWAY. The company has a market capitalization of approximately $651.3 million. Brainsway specializes in developing and commercializing innovative medical technologies, particularly in the field of neuromodulation.
Latest news from Brainsway Ltd
BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation
August 27, 2026
BrainsWay Announces Minority-Stake Investment in Hopemark Health
May 18, 2026
BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026
April 29, 2026
BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 13, 2026
Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy...
March 30, 2026
Brainsway Ltd earnings calls
BrainsWay Ltd. (BWAY) Q2 2026 Earnings Call
August 12, 2026 · Replay with transcript and chapters
BrainsWay Ltd. (BWAY) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
BrainsWay Ltd. (BWAY) Q4 2025 Earnings Call
March 11, 2026 · Replay with transcript and chapters
BrainsWay Ltd. (BWAY) Q3 2025 Earnings Call
November 11, 2025 · Replay with transcript and chapters
BrainsWay Ltd. (BWAY) Q2 2025 Earnings Call
August 13, 2025 · Replay with transcript and chapters
BrainsWay Ltd. (BWAY) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Brainsway Ltd
Brainsway Ltd investor report
Review AI stock analysis and investor report context for BWAY:NASDAQ.
Brainsway Ltd company profile
View the public company page for Brainsway Ltd on 6ix.
Brainsway Ltd news
Read company news and market updates connected to Brainsway Ltd.
Brainsway Ltd investor events
Find investor webinars, events, and replay context for Brainsway Ltd.
Alternate listings
BWAY:TASE
IL · ILA
Alternate listing for Brainsway Ltd; the primary context on this page is BWAY:NASDAQ.
BRSYF:OTC
US · USD
Alternate listing for Brainsway Ltd; the primary context on this page is BWAY:NASDAQ.
BWAY:BOATS
US · USD
Alternate listing for Brainsway Ltd; the primary context on this page is BWAY:NASDAQ.